{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-017051","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2022-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.447535+00:00","generated_at":"2026-06-26T02:38:24.515252+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"First Wave BioPharma reports mixed Phase 2 trial for COVID-19 GI; cuts 20% of staff","bullets":["Phase 2 RESERVOIR trial: FW-COV (niclosamide) safe but missed efficacy endpoint vs placebo on SARS-CoV-2 stool viral clearance.","Austerity measures: 20% headcount reduction, closure of West Coast office and Langlade, France facility.","Deferred certain payment obligations related to First Wave Bio, Inc. acquisition to conserve capital.","Awaiting full RESERVOIR data in late May; advancing IBD programs (FW-UP, FW-UC, FW-CD) and adrulipase for EPI.","David Hoffman appointed to Board, filling newly created seventh seat under merger agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-017051","json":"https://secwatch.observer/filing/0001140361-22-017051.json","markdown":"https://secwatch.observer/filing/0001140361-22-017051.md","text":"https://secwatch.observer/filing/0001140361-22-017051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122017051/0001140361-22-017051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122017051/brhc10036952_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T02:38:24.515252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c5e7fb9c0","claim":"David Hoffman was appointed as Member of the Board at GridAI Technologies Corp..","evidence_excerpt":"approved, effective immediately, an increase in the size of the Board from six directors to seven directors and appointed David Hoffman, age 61, to serve as a member of the Board to fill the newly-created vacancy.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000114036122017051/0001140361-22-017051-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}